When: Tuesday 8th September 2020 at 12:30 – 14:00 BST
Get the latest insights and information for accelerating patient access
Understand the value and importance of patient engagement throughout the HTA process
Discover the benefits of using patient registries in HTAs
Compare the appraisal process of medical devices compared with drugs and pinpoint what can be learnt from each process
Who would benefit from registering to attend this webinar:
This webinar should be attended by representatives from UK, European and global pharmaceutical, biotech, life science and MedTech industries, as well as patient organisations and patient groups.
The job functions that will benefit most include:
• Heads of Market Access
• Managing Directors
• Country Managers
• Chief Executives
• Health Economists
• Medical Directors
• Commercial Directors
• Policy Officers/Executives
• Marketing Directors
• Policy Advisors
Lindsay has championed and led patient groups throughout her career. Starting with St Johns Ambulance, Cheshire Young Carers, she has latterly held Chief Executive Officer positions at the Young Carers Network and Children Living with Inherited Metabolic Disorders.
David is an experienced VP within the biotechnology industry. He is skilled in Oncology, Haematology, and Pharmacovigilance. In addition, be being the Vice President International Medical Affairs at Vertex, he is also their international GMDA lead.
Health Economist Jasdeep has been with NICE for 9 years in a range of technical with responsibility across commissioning and management of contractors and leading on overall economic outputs for safe staffing guidelines.
Copyright © 2020. MAP BioPharma Limited. All rights reserved.
MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
+44 (0) 1480 832360
MAP BioPharma Limited is a registered company in England and Wales. Company Registration Number 08209281
VAT Group Registration Number GB 292 8576 52